97 related articles for article (PubMed ID: 28487238)
21. Donor and recipient chemokine receptor CCR5 genotype is associated with survival after bone marrow transplantation.
McDermott DH; Conway SE; Wang T; Ricklefs SM; Agovi MA; Porcella SF; Tran HT; Milford E; Spellman S; Abdi R
Blood; 2010 Mar; 115(11):2311-8. PubMed ID: 20068218
[TBL] [Abstract][Full Text] [Related]
22. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
23. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
Devine SM; Geller RB; Lin LB; Dix SP; Holland HK; Maurer D; O'Toole K; Keller J; Connaghan DG; Heffner LT; Hillyer CD; Rodey GE; Winton EF; Maher RM; Fitzsimmons WE; Wingard JR
Biol Blood Marrow Transplant; 1997 Apr; 3(1):25-33. PubMed ID: 9209738
[TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium study.
Goyal RK; Lin Y; Schultz KR; Ferrell RE; Kim Y; Fairfull L; Livote E; Yanik G; Atlas M
Biol Blood Marrow Transplant; 2010 Jul; 16(7):927-936.e1. PubMed ID: 20100586
[TBL] [Abstract][Full Text] [Related]
25. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants.
Al-Kasim FA; Thornley I; Rolland M; Lau W; Tsang R; Freedman MH; Saunders EF; Calderwood S; Doyle JJ
Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456
[TBL] [Abstract][Full Text] [Related]
26. Novel HLA-DP region susceptibility loci associated with severe acute GvHD.
Goyal RK; Lee SJ; Wang T; Trucco M; Haagenson M; Spellman SR; Verneris M; Ferrell RE
Bone Marrow Transplant; 2017 Jan; 52(1):95-100. PubMed ID: 27595289
[TBL] [Abstract][Full Text] [Related]
27. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
[TBL] [Abstract][Full Text] [Related]
28. Impact of incompatible killer cell immunoglobulin-like receptor and its ligand on the outcome of haploidentical bone marrow transplantation.
Duan LN; Han HX; Liu J; Yan HM; Zhu L; Xue M; Ding L; Zhu PY; Wang HX; Ji SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):809-15. PubMed ID: 17708809
[TBL] [Abstract][Full Text] [Related]
29. Clinical separation of cGvHD and GvL and better GvHD-free/relapse-free survival (GRFS) after unrelated cord blood transplantation for AML.
Zheng CC; Zhu XY; Tang BL; Zhang XH; Zhang L; Geng LQ; Liu HL; Sun ZM
Bone Marrow Transplant; 2017 Jan; 52(1):88-94. PubMed ID: 27376453
[TBL] [Abstract][Full Text] [Related]
30. The predictive value of helper T lymphocyte precursor frequencies for graft-versus-host disease and graft-versus-leukaemia effects in allogeneic bone marrow transplantation.
Russell CA; Heilmann C; Madsen HO; Vindeløv LL
Bone Marrow Transplant; 2001 May; 27(9):949-58. PubMed ID: 11436105
[TBL] [Abstract][Full Text] [Related]
31. Dynamic Detection of Anti-Human Leukocyte Antigen (HLA) Antibodies but not HLA-DP Loci Mismatches Can Predict Acute Graft-versus-Host Disease and Overall Survival in HLA 12/12-Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies.
Pan Z; Yuan X; Li Y; Wu X; Zhu W; Bao X; Zhao Q; He J
Biol Blood Marrow Transplant; 2016 Jan; 22(1):86-95. PubMed ID: 26283096
[TBL] [Abstract][Full Text] [Related]
32. Comparable outcome after single-antigen-mismatched versus matched unrelated donor haematopoietic cell transplantation.
Rockstroh A; Al-Ali HK; Lange T; Pönisch W; Krahl R; Cross M; Behre G; Niederwieser D; Pfrepper C
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2193-203. PubMed ID: 26129640
[TBL] [Abstract][Full Text] [Related]
33. Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies.
Baker M; Wang H; Rowley SD; Cai L; Pecora AL; Skarbnik A; Vesole DH; Adler-Brecher B; Kim D; Donato ML
Biol Blood Marrow Transplant; 2016 Nov; 22(11):2047-2055. PubMed ID: 27522040
[TBL] [Abstract][Full Text] [Related]
34. Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update.
Arcese W; Picardi A; Santarone S; De Angelis G; Cerretti R; Cudillo L; Pennese E; Bavaro P; Olioso P; Dentamaro T; Cupelli L; Chierichini A; Ferrari A; Mengarelli A; Tirindelli MC; Testi M; Di Piazza F; Di Bartolomeo P;
Bone Marrow Transplant; 2015 Jun; 50 Suppl 2():S24-30. PubMed ID: 26039203
[TBL] [Abstract][Full Text] [Related]
35. The impact of the dose of natural killer cells in the graft on severe acute graft-versus-host disease after unrelated bone marrow transplantation.
Tanaka M; Kobayashi S; Numata A; Tachibana T; Takasaki H; Maruta A; Ishigatsubo Y; Kanamori H
Leuk Res; 2012 Jun; 36(6):699-703. PubMed ID: 22172462
[TBL] [Abstract][Full Text] [Related]
36. Low Counts of Plasmacytoid Dendritic Cells after Engraftment Are Associated with High Early Mortality after Allogeneic Stem Cell Transplantation.
Gonçalves MV; Yamamoto M; Kimura EY; Colturato VA; de Souza MP; Mauad M; Ikoma MV; Novis Y; Rocha V; Ginani VC; Wanderley de Oliveira Felix OM; Seber A; Kerbauy FR; Hamerschlak N; Orfao A; Rodrigues CA
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1223-9. PubMed ID: 25792371
[TBL] [Abstract][Full Text] [Related]
37. The recipient CXCL10 + 1642C>G variation predicts survival outcomes after HLA fully matched unrelated bone marrow transplantation.
Nakata K; Takami A; Espinoza JL; Matsuo K; Morishima Y; Onizuka M; Fukuda T; Kodera Y; Akiyama H; Miyamura K; Mori T; Nakao S;
Clin Immunol; 2013 Feb; 146(2):104-11. PubMed ID: 23291247
[TBL] [Abstract][Full Text] [Related]
38. Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update.
Bacigalupo A; Dominietto A; Ghiso A; Di Grazia C; Lamparelli T; Gualandi F; Bregante S; Van Lint MT; Geroldi S; Luchetti S; Grasso R; Pozzi S; Colombo N; Tedone E; Varaldo R; Raiola AM
Bone Marrow Transplant; 2015 Jun; 50 Suppl 2():S37-9. PubMed ID: 26039205
[TBL] [Abstract][Full Text] [Related]
39. Unrelated bone marrow transplantation in children: outcome and a comparison with sibling donor grafting.
Gustafsson A; Remberger M; Winiarski J; Ringdén O
Bone Marrow Transplant; 2000 May; 25(10):1059-65. PubMed ID: 10828866
[TBL] [Abstract][Full Text] [Related]
40. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
